Fundz

Vistagen Appoints Cindy Anderson as Chief Financial Officer

PUBLIC · VTGNAug 22, 2023

Company

VistaGen

Cindy Anderson
canderson@vistagen.com
South San FranciscoBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Vistagen a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system disorders, today announced the appointment of Cindy Anderson as Chief Financial Officer , effective August 21, 2023. Ms. Anderson will succeed Jerrold Dotson, whose planned retirement was announced in July of this year.

Quick answer

Vistagen Appoints Cindy Anderson as Chief Financial Officer (August 22, 2023). VistaGen is based in South San Francisco, California, United States.

What did VistaGen announce on August 22, 2023?
Vistagen a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system disorders, today announced the appointment of Cindy Anderson as Chief Financial Officer , effective August 21, 2023. Ms. Anderson will succeed Jerrold Dotson, whose planned retirement was announced in July of this year.
What does VistaGen do?
Vistagen is a late clinical-stage biopharmaceutical company headquartered in South San Francisco, CA, developing and commercializing a new class of intranasal product candidates called pherines.
Where is VistaGen based?
VistaGen is based in South San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
LumaBridge (August 8, 2023), Madrigal Pharmaceuticals (September 14, 2023), Pfizer (July 27, 2023) and Acadia Pharmaceuticals (July 25, 2023) also announced leadership changes within 45 days of VistaGen.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at VistaGen, and when

A new leader at VistaGen brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day VistaGen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VistaGen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VistaGen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VistaGen

Location

343 Allerton Avenue

South San Francisco, California, United States

About

Vistagen is a late clinical-stage biopharmaceutical company headquartered in South San Francisco, CA, developing and commercializing a new class of intranasal product candidates called pherines. Leveraging advanced insights into nose-to-brain neurocircuitry, Vistagen designs pherines to selectively activate peripheral nasal chemosensory receptors and rapidly trigger olfactory bulb–to-brain pathways that influence behavior and autonomic nervous system activity. Because they are engineered to work without entering the bloodstream or brain, pherines have the potential to offer safer therapeutic alternatives to existing pharmacological treatments if successfully developed and approved.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VistaGen changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Cindy
Likely contact at this company
••••••••@••••••••

See Cindy's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for VistaGen's next move

Learn about Strategic plan

VistaGen changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.